Kate Middleton Shares New Message After Dropping Out of Royal Ascot Appearance
The Princess of Wales, 43, praised them for lifting the spirits of children and families "through life, death and beyond"
Her June 20 message, as Children's Hospice Week draws to an end, came six months after she took on the role of patron to a hospice in South WalesKate Middleton is showing her support for kids' hospices in a poignant week.
In a new message issued on Friday, June 20, the Princess of Wales praised how hospices 'lift the spirits' and support seriously ill children and their families through 'life, death and beyond.'
She said it was an 'immense privilege' seeing the work up close of two hospices, with East Anglia's Children's Hospices and Tŷ Hafan Children's Hospice, during her visits as their patron.
It came in a week when Princess Kate, 43, dropped out of an expected visit to the Royal Ascot race meeting on Wednesday. Kate is still managing her return to public-facing duties amid her recovery from cancer treatment.
In her message on June 20, Kate wrote, 'No parent expects to hear that their child has a serious health condition that could shorten their life. Sadly, this is the reality faced by thousands of families across the country, leaving them heartbroken, fearful of the future and often desperately isolated."
'Being able to access the support of one of the U.K.'s 54 children's hospices means they don't have to face that future alone," she added.
'As Patron of East Anglia's Children's Hospices and Tŷ Hafan Children's Hospice in South Wales, I have the immense privilege of seeing for myself the extraordinary work of our children's hospices," she said. "Lifting spirits through laughter, fun and play, as well as listening, holding, caring and sharing, they support children and families through life, death and beyond."
"This Children's Hospice Week, I hope you will join me in celebrating the life-changing work they do and thanking them for the vital care they provide to children and families experiencing the most challenging times," Kate concluded.
Support for children's hospices has been an ever-present part of Princess Kate's public work since she started in public life soon after marrying Prince William in 2011. She has also visited hospices around the world during her overseas tours.
During Children's Hospice Week, which ends on June 22, the charity Together for Short Lives brings together the vital services to celebrate the incredible work they do for seriously ill children and their families.
Kate made her first visit to Tŷ Hafan in January, spending more time than she was scheduled, crouching down, talking to youngsters and their families and joining in with the games. Tŷ Hafan — which means "Haven House" in Welsh — is located in Sully, South Wales, and was built with the support of Prince William's late mother, Princess Diana.
Tracy Jones, the director of family well-being services who showed Kate around, said on the day of the visit in January, 'She immediately gravitated to the children and families — she spent quality time talking to every child and their parents.'
'It's been the most inspiring visit,' Jones added. 'She crouched down and was straightaway on the level of the children. If they were in a wheelchair, she crouched at that level. If they were on the floor, she would be at the level,' she continues. 'We were seriously impressed with how she could stay in a crouch, as it's not that comfortable!"
"She instinctively seemed to know where to touch a child that was going to provide the connection, but not cause any distress or startle a child. She was looking at the children, even if she was talking to the parent. It's what we do, as we're used to working with children who are nonverbal," she added.
Nick Carroll, CEO of Together for Short Lives, praised Kate's "ongoing support for Children's Hospice Week over many years [that] has helped to raise much-needed awareness of the life-changing work children's hospices do, every day of the year."
"Their extraordinary lifeline care for children with life-limiting and life-threatening illnesses enables families to make the most of their lives together, whether that's for years, months or only hours," he said. 'Together with all the children's hospices, we thank the Princess of Wales for her invaluable contribution.'
Irfon Rees, Chief Executive of Tŷ Hafan Children's Hospice, said in a statement on June 20, 'Her Royal Highness is clearly profoundly committed to the needs of children and young people, and in January, during her first visit to our hospice as our patron, her kindness and empathy were evident."
'Having HRH's support during Children's Hospice Week means that not only can we take time to celebrate the difference that children's hospices, including Tŷ Hafan, have made to the lives of so many families, but that we can also remind people of the importance of supporting their local children's hospice so that no family has to live their child's short life alone.'
Can't get enough of PEOPLE's Royals coverage? to get the latest updates on Kate Middleton, Meghan Markle and more!
Kevin Clements, Chief Executive of EACH, based in the area close to the Wales family's country home, Anmer Hall, in Norfolk, added, 'We're so incredibly grateful for The Princess' invaluable contribution as our dedicated Royal Patron. Her ongoing support and vast profile have projected our charity onto the global stage, and this latest message is a perfect way to mark Children's Hospice Week."
'It's a great opportunity to shine a light on the work of children's hospices generally, as well as giving us an opportunity to raise awareness and remind everyone of the need for public support, given we rely on donations for the majority of our income.'
Read the original article on People
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
44 minutes ago
- Medscape
Can Blocking AMH Reverse PCOS? New Study Says Yes
Researchers from the French National Institute of Health & Medical Research (Inserm), University of Lille in Lille, France, and the university's teaching hospital CHU de Lille have identified a promising new therapeutic strategy for polycystic ovary syndrome (PCOS). In preclinical models, the use of antibodies that block the activity of anti-Müllerian hormone (AMH) helped prevent the onset of PCOS-like symptoms — and even reversed them in adults who were already affected. Paolo Giacobini, PhD, neuroendocrinologist and group leader at Inserm's Lille Neuroscience and Cognition Research Center (Centre de recherche Lille Neuroscience et Cognition), shared the findings with Medscape's French edition . Reduced Quality of Life PCOS is one of the most common causes of infertility among women of reproductive age, affecting approximately 1 in 10 women — or more than two million individuals in France alone. Currently, treatment options are limited to symptom management. 'This condition has a significant impact on women's quality of life,' said Giacobini. 'It presents with a broad spectrum of symptoms that vary between patients, including polycystic ovaries, elevated androgen levels leading to menstrual irregularities, acne, hair loss, excessive body hair, high levels of AMH, and, in some cases, metabolic syndrome. At least half of women with PCOS have associated comorbidities such as overweight or obesity, elevated insulin levels that increase the risk of developing type 2 diabetes, or cardiovascular disease.' A Multifactorial Condition Diagnosis of PCOS is typically based on the presence of at least two of the following three criteria: irregular menstrual cycles, clinical or biochemical signs of hyperandrogenism, and polycystic ovarian morphology as observed via ultrasound. The exact cause of PCOS remains unclear. 'We've done extensive laboratory research using preclinical models to better understand the heritability of the syndrome,' Giacobini said. 'Genetics are a factor, but they do not fully explain the high prevalence. We've also identified epigenetic changes and environmental influences, such as hormonal exposures during fetal development or after birth. It is highly likely that PCOS has a multifactorial origin.' In a recent study, Giacobini's team focused on the role of AMH. In PCOS, the ovaries produce excess AMH, which impairs the maturation of follicles and contributes to androgen overproduction. 'In previous preclinical studies, we found that prenatal exposure to AMH could induce PCOS-like symptoms in offspring, and these symptoms were transmitted across generations,' Giacobini explained. 'We then examined critical periods of vulnerability in humans and observed that children of women with PCOS — both daughters and sons — had elevated AMH levels, even before puberty. We also found that mice exhibited high AMH levels during 'mini-puberty,' a transient hormonal phase in early infancy.' Blocking AMH Receptors The research team next investigated whether blocking AMH could help prevent PCOS. To do this, they developed a novel antibody, Ha13, designed to block AMH receptors located both in the ovaries and on gonadotropin-releasing hormone (GnRH)-producing neurons, which regulate reproductive function. 'By administering this antibody to young mice during the mini-puberty phase, we were able to prevent the development of PCOS in adulthood,' said Giacobini. 'And when we treated adult mice already exhibiting PCOS symptoms, we reversed all reproductive abnormalities — normalizing menstrual cycles, ovulation, and androgen levels.' Giacobini views this study as 'a gateway to further research on the pharmacokinetics of this antibody, which could eventually pave the way for human trials.' Although the molecule has been patented, several steps remain before it can be considered for clinical use. 'The effects in animals are very promising, but we still need to evaluate long-term outcomes and establish optimal dosing,' he emphasized. An Advanced Alternative Another therapeutic avenue targeting the GnRH receptor is already further along in development. 'We published our preclinical research on GnRH antagonists in 2018, and, thanks to European funding, we were able to initiate clinical trials. The pilot-phase results have been encouraging,' Giacobini said. 'One advantage is that this molecule is already approved by the US Food and Drug Administration and the European Medicines Agency for other indications. We're already familiar with its pharmacological profile and side effects, which significantly accelerates development,' he concluded.
Yahoo
an hour ago
- Yahoo
Mum pens book to help children cope with hospital
A Surrey author has written a book designed to help children cope with a stay in hospital. Bex Grace wrote The Hospital Stay with Frimley Health with input from Frimley Park Hospital's paediatric team. Bex and her two children were born at the hospital and she is a member of the Maternity Voices Frimley group. A hospital spokesperson said the book offered "clear, age-appropriate communication and playful storytelling to reduce anxiety and empower children, while supporting parents and carers to guide their children through the experience". Every illustration is based on real scenes from hospitals at the trust, where 25% of all patients are children. James Clarke, the trust's chief strategy officer at Frimley Heath NHS Foundation Trust, said: "When I visited the hospital with my own four-year-old, I saw first-hand how many questions young children have and how important it is to help them feel at ease. "This book is a beautiful example of how we can make our ambitions real for children and families, helping them understand what great care looks like. "Bex's story is one of giving back, she's a local author, a parent, and a true partner in our mission to make hospital care better for everyone." The Hospital Stay with Frimley Health is available now on the Frimley Health Charity website, which will receive all profits from book sales. Follow BBC Surrey on Facebook, on X. Send your story ideas to southeasttoday@ or WhatsApp us on 08081 002250. Hospitals in South East given £67m for repairs Hospital extension welcomes first patients Frimley Health NHS Foundation Trust
Medscape
an hour ago
- Medscape
Think Beyond Stroke in Sudden Facial Droop
Infectious mononucleosis (IM), also known as the kissing disease or 'mono,' is typically caused by the Epstein-Barr virus (EBV). It is a clinical condition characterised by fever, lymphadenopathy, and pharyngitis. Bell's palsy is a condition that causes sudden, temporary facial paralysis or weakness on one side of the face. It can have various aetiologies, such as congenital, neurologic, infectious, neoplastic, or traumatic. This report describes the case of a woman who was diagnosed with Bell's palsy, a rare neurologic complication of EBV-associated IM. The Patient and Her History An 18-year-old woman with a medical history of low back pain and sinusitis presented to the clinic with complaints of fever, sore throat, and left-sided facial drooping. She reported noticing these symptoms 1 week prior. The neck pain had progressively worsened and radiated to the left ear. The patient also experienced difficulty forming words and was unable to raise her left eyebrow or smile due to facial drooping. She noted no improvement with over-the-counter medications and denied recent travel. Findings and Diagnosis On physical examination, several 1-cm mobile tender anterior cervical lymph nodes were noted. Tonsillitis with white exudates and left ear tympanosclerosis with associated pain were observed. The left corner of the mouth was drooping, and the patient had difficulty making facial expressions and closing her left eye. The spleen was palpable and tender to touch. Neurologic examination showed that all other cranial nerves were grossly intact. The muscle strength was 5/5 in both the upper and lower extremities, and deep tendon reflexes were present throughout. The lungs were clear to auscultation, and pulses were palpable in all extremities. No oedema, cyanosis, or clubbing was observed. The skin was dry, and no rashes were observed. Laboratory tests showed mild leucocytosis. Rapid antigen tests for streptococci, influenza, and COVID were negative. A rapid heterophile antibody test for EBV was positive. The mononucleosis spot test was positive for reactive heterophile antibodies, a hallmark finding of IM. Immunofluorescence assays showed positive immunoglobulin M and immunoglobulin G antibodies against EBV, with the presence of immunoglobulin M antibodies indicating either a recent primary infection or a reactivated infection. On the basis of these findings, a diagnosis of left-sided Bell's palsy due to EBV infection was confirmed. The patient was prescribed prednisone 60 mg for 1 week, with a plan to taper the dose. Tylenol was recommended for pain management as needed. Artificial tears were prescribed to prevent corneal damage and dryness due to the inability to close the left eye. An ear, nose, and throat (ENT) referral was made for the evaluation of left ear tympanosclerosis and associated pain. The patient was counselled to avoid contact sports because of the risk for splenic rupture, a common complication of IM. At the 2-week follow-up, the patient reported symptoms such as runny nose, fatigue, and ongoing ear pain, pending evaluation by an ENT specialist. At that time, there was no evidence of lymphadenopathy, fever, or splenomegaly. The patient's facial paralysis had improved by approximately 70%, and her speech was also markedly improved. The patient was counselled to rest, stay hydrated, and closely monitor for new symptoms. Discussion IM, most often caused by the EBV, is a viral illness that primarily affects teenagers and young adults. It is transmitted through saliva — which is why it is often referred to as the 'kissing disease' — but can also be spread via respiratory droplets, blood, or organ transplants. Symptoms may include sore throat, fever, swollen lymph nodes, and extreme fatigue, as well as swelling of the liver and spleen. A heterophile antibody test is typically sufficient to diagnose IM. Most people recover on their own with rest, fluids, and over-the-counter pain relievers. However, in rare cases, complications such as a ruptured spleen, neurologic issues, or liver inflammation can occur. Neurologic complications, such as cranial nerve palsies, Guillain-Barré syndrome, meningoencephalitis, and mononeuritis multiplex, occur in approximately 1%-5% of all patients with acute EBV infection. In children, neurologic manifestations may be the only clinical sign that can occasionally delay diagnosis. Acute peripheral facial paralysis is the most common acute mononeuropathy and often presents a diagnostic challenge for physicians. Its incidence has been reported as 21.1 per 100,000 per year in children younger than 15 years. Paediatric facial nerve paralysis can be congenital or acquired, but the idiopathic form, known as Bell's palsy, is the most frequent, accounting for 40%-75% of cases. Bell's palsy is diagnosed by the abrupt onset of unilateral facial weakness or complete paralysis of all muscles on one side of the face. It may be accompanied by dry eyes, pain around the ear, an altered sense of taste, hypersensitivity to sounds, or decreased tearing. Recovery time varies, but complete resolution of symptoms usually occurs within 2-3 weeks. There is always a small possibility of permanent functional loss, which can result from structural damage to axons and myelin. Treatment is usually supportive, often involving a combination of steroids and, in some cases, physical therapy. Facial nerve palsy is most often idiopathic and related to microcirculatory changes but may also result from congenital defects, infections, trauma, neoplasms, or systemic illness. Infectious causes account for 5%-30% of cases and are the most common cause in young children. Common pathogens include herpes simplex virus 1, varicella-zoster virus, EBV, Borrelia burgdorferi , HIV, and influenza virus. The causes of facial palsy are classified as follows: Genetic: Hereditary myopathies, gene mutations Syndromic: Craniofacial malformations and brainstem disorders Delivery-related: Prematurity, instrumental delivery, caesarean section Infectious: Viral, bacterial, and fungal agents including chronic or acute otitis media Inflammatory: Autoimmune and vasculitis conditions Neoplastic: Tumours involving the facial nerve or surrounding structures Traumatic: Skull fractures affecting the facial nerve Iatrogenic: Injury during head and neck surgeries Idiopathic: Bell's palsy Timely diagnosis and stroke exclusion are critical to avoid permanent damage. Lyme disease should be ruled out, especially in patients with recent travel to endemic areas and a bull's eye rash.
